Amarin Corp Plc (AMRN) Posts Q3 adj.Loss of 26c/Share; Updates on Vascepa Approvals, Exclusivity

November 8, 2012 4:29 PM

Amarin Corp Plc (NASDAQ: AMRN) reported Q3 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22).

Vascepa ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found